Maternal–fetal tolerance: why the fetus is not rejected
- Process
Half of a baby's genes come from the father, yet the mother does not reject it like a transplant; the placenta and uterus actively prevent it.
What it is
The fetus carries paternal HLA and other antigens and is in effect a semi-foreign graft. Pregnancy succeeds because the placenta limits what it shows to the mother, uterine immune cells are reprogrammed to support the placenta, and regulatory T cells specific for paternal antigens expand. Tolerance is not complete: mothers can make antibodies against fetal red cells, platelets and HLA, and maternal IgG crossing the placenta can affect the newborn.
Key facts
- HLA-G is expressed almost only by trophoblast and inhibits NK and T cells.
- Maternal IgG crosses the placenta through FcRn, giving the newborn passive protection.
- Fetal cells persist in the mother for years (microchimerism).
Step by step
- The syncytiotrophoblast facing maternal blood has no classical HLA-A, -B or class II, so T cells have nothing to target.
- Invading trophoblast shows HLA-C, -E and -G, which engage inhibitory receptors on uterine NK cells.
- Uterine NK cells (CD56-bright) make growth factors that remodel spiral arteries instead of killing.
- Tregs specific for paternal antigens expand; decidual cells silence chemokines that would bring effector T cells.
- Complement regulators (CD55, CD59) on trophoblast limit local complement attack.
- Maternal IgG still crosses via FcRn, giving the newborn protection but also carrying any harmful antibodies.
Why the fetus survives but a kidney graft would not
| Feature | Fetus (semi-allograft) | Organ allograft |
|---|---|---|
| HLA facing the host | None classical on syncytiotrophoblast; HLA-C, -E, -G on invading trophoblast | All donor HLA class I, and class II on APCs and activated endothelium |
| Donor antigen-presenting cells | Not carried into maternal nodes in a way that primes rejection | Passenger dendritic cells drive direct allorecognition |
| Host NK cells | Inhibited; help build blood vessels | Can kill cells lacking self class I |
| Regulatory T cells | Antigen-specific Tregs expand naturally | Need drugs to suppress responses |
| Antibody | Maternal IgG crosses; HDFN or alloimmune thrombocytopenia if sensitised | Donor-specific antibodies cause antibody-mediated rejection |
Clinical notes
- Haemolytic disease of the fetus and newborn: an Rh-negative mother sensitised to fetal RhD makes IgG that crosses the placenta; anti-D immunoglobulin prevents it.
- Fetal and neonatal alloimmune thrombocytopenia: maternal antibodies against paternal platelet antigens (often HPA-1a).
- Pregnancies sensitise to HLA, so multiparous women may have anti-HLA antibodies relevant for transplants and transfusions.
- Transplacental autoantibodies cause neonatal lupus (anti-Ro and congenital heart block), neonatal Graves disease and transient neonatal myasthenia.
- Rheumatoid arthritis often improves during pregnancy; multiple sclerosis relapses fall in late pregnancy and rise after delivery; lupus may flare.
Common traps
- The fetus is hidden from the maternal immune system: fetal cells and antigens reach the mother, and tolerance is active, not ignorance.
- Uterine NK cells are killers that must be suppressed: in pregnancy they mainly build the placenta's blood supply.
- Maternal antibodies only protect the newborn: harmful IgG also crosses (anti-RhD, anti-HPA-1a, anti-Ro, anti-TSH receptor).
- Every autoimmune disease improves in pregnancy: RA and MS often improve, but lupus may flare.
Test yourself
Think of the answer, then tap the question to see it.
Why can maternal T cells not target the syncytiotrophoblast that is bathed in maternal blood?
It expresses no classical HLA-A, -B or class II, so there is no allogeneic MHC for T cells to recognise.
Why does trophoblast express HLA-G and HLA-E instead of simply having no HLA at all?
Cells with no class I are killed by NK cells (missing self); HLA-E and -G engage NK inhibitory receptors and prevent that.
A mother with Sjögren syndrome has a baby with complete heart block. What crossed the placenta and how?
Anti-Ro (SSA) IgG, carried by FcRn; it damages the fetal conduction system.
Why can a woman with several pregnancies have trouble finding a compatible kidney or platelet donor?
Each pregnancy can sensitise her to paternal HLA, so she may carry anti-HLA antibodies against many donors.
Elsewhere in DurgiPedia
Connections
Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.
Sources: Rh incompatibility (MedlinePlus, US National Library of Medicine, 2024); Immune response (MedlinePlus, US National Library of Medicine, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
